Compound class:
Synthetic organic
Comment: RMC-6291 is a tri-complex KRASG12C(ON) inhibitor, that was developed for anti-tumour potential. It inhibits active, GTP-bound RAS. The chemical structure was disclosed during the 'First Disclosures of New Drug Candidates' session at the April 2023 meeting of the AACR in Orlando.
|
|
For advanced searching click here to open chemical structure editor